Phase II Study of Adjuvant Everolimus on Pancreatic Neuroendocrine Tumors of the Liver
1 Views
administrator
07/13/23
Steven Libutti, MD, discusses a Phase II study that examines the effectiveness of adjuvant everolimus on metastatic pancreatic neuroendocrine tumors of the liver.
http://www.montefiore.org/cancer
-
Category
Show more
Facebook Comments
No comments found